GeoVax Labs Inc News - GOVXW

GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Company to Provide Updates on Multiple Phase 2 Clinical Trials for GEO-CM04S1 and Gedeptin® ATLANTA, GA, Aug...

GeoVax Receives Notice of Allowance for Malaria Vaccine Patent

Patent Covers Multiple Component Vaccine for Both Prevention and Treatment ATLANTA, GA, Aug. 28, 2023 (GLOBE...

GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

ATLANTA, GA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Seeking Improved Immune Response vs mRNA Vaccine Full Patient...

GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update

Progress and Promising Outlook for Gedeptin® and GEO-CM04S1; Phase 2 GEO-CM04S1; Clinical Trial Initiated for...

GeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023

GeoVax to Host Second Quarter 2023 Conference Call at 4:30 PM ET ATLANTA, GA, July 26, 2023 (GLOBE NEWSWIRE...

GeoVax Announces Issuance of Ebola Vaccine Patent

Addressing Multiple Strains of Ebolavirus ATLANTA, GA, July 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire...

GeoVax Announces Initiation of Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

Seeking Improved Immune Response vs mRNA Vaccine ATLANTA, GA, July 20, 2023 (GLOBE NEWSWIRE) -- via...

GeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer Conference

ATLANTA, GA, July 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a...

GeoVax Announces Gedeptin® Presentation at the AACR-AHNS Head and Neck Cancer Conference

ATLANTA, GA, June 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a...

GeoVax Universal Coronavirus Vaccine Design & Development Approach Published in Vaccine Insights

Spotlight Content on Pandemic Preparedness: Getting Ready for the Next “Disease X” ATLANTA, GA, June 27, 2023...

GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates

ATLANTA, GA, May 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a...

GeoVax to Participate in Upcoming Industry Meetings

Management to participate in 2023 ASCO Annual Meeting and 2023 BIO International Convention ATLANTA, GA, May...

GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients

New and Unpublished Data from Phase 2 Open-Label Safety Study ofGEO-CM04S1 Presented at Two Recent Scientific...

GeoVax Next-Generation COVID-19 Vaccine Data to be Presented at Two Upcoming Scientific Meetings

Presentations to Include New and Unpublished Data from Phase 2 Open-Label Safety Study of GEO-CM04S1 ATLANTA...

GeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conference

ATLANTA, GA, May 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

GeoVax Labs Inc (GOVXW)

Empower your portfolio: Real-time discussions and actionable trading ideas.

GOVXW News

GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GeoVax Receives Notice of Allowance for Malaria Vaccine Patent

GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update

GeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023

GeoVax Announces Issuance of Ebola Vaccine Patent

GeoVax Announces Initiation of Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer Conference

GeoVax Announces Gedeptin® Presentation at the AACR-AHNS Head and Neck Cancer Conference

GeoVax Universal Coronavirus Vaccine Design & Development Approach Published in Vaccine Insights

GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates

GeoVax to Participate in Upcoming Industry Meetings

GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients

GeoVax Next-Generation COVID-19 Vaccine Data to be Presented at Two Upcoming Scientific Meetings

GeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conference

GOVXW Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

GeoVax Labs Inc (GOVXW) News

GeoVax Labs Inc (GOVXW)

Empower your portfolio: Real-time discussions and actionable trading ideas.

GOVXW News

GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GeoVax Receives Notice of Allowance for Malaria Vaccine Patent

GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update

GeoVax to Report Second Quarter 2023 Financial Results and Provide Corporate Update on Wednesday, August 9, 2023

GeoVax Announces Issuance of Ebola Vaccine Patent

GeoVax Announces Initiation of Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

GeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS Head and Neck Cancer Conference

GeoVax Announces Gedeptin® Presentation at the AACR-AHNS Head and Neck Cancer Conference

GeoVax Universal Coronavirus Vaccine Design & Development Approach Published in Vaccine Insights

GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates

GeoVax to Participate in Upcoming Industry Meetings

GeoVax’s Next-Generation COVID-19 Vaccine Shows High Immunogenicity in Immunocompromised Patients

GeoVax Next-Generation COVID-19 Vaccine Data to be Presented at Two Upcoming Scientific Meetings

GeoVax Labs to Participate in A.G.P.’s Virtual Healthcare Conference

GOVXW Discussion

Your Recent History